Bio-Rad Laboratories Inc. (California, U.S)
Other Players
Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Industry Developments:
June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.
Bio-Rad Laboratories Inc. (California, U.S)
Other Players
Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Industry Developments:
June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.
PerkinElmer Inc. (U.S.)
Eurofins LifeCodexx GmbH (Germany)
COVID-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers
The COVID-19 pandemic has had an adverse effect on several industries across the world. Several reputed companies operating in the non-invasive prenatal testing industry are constantly keeping in touch with the U.S. FDA to get to know detailed information about supply chain disruptions. Also, research institutes are conducting many studies to determine the effect of the coronavirus on births and pregnancies. SeraCare’s report, for instance, declares that clinical testing laboratories and in-vitro diagnostics manufacturers are working closely to determine the interference of SARS-CoV-2 infection on childbirths.